• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.一项关于使用抗菌封套预防心血管植入式电子设备感染的荟萃分析。
Ther Adv Infect Dis. 2017 May;4(3):75-82. doi: 10.1177/2049936117702317. Epub 2017 May 1.
2
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.抗菌包膜与植入式心脏复律除颤器和心脏再同步治疗装置更换后的低感染率相关:Citadel 和 Centurion 研究的结果。
JACC Clin Electrophysiol. 2017 Oct;3(10):1158-1167. doi: 10.1016/j.jacep.2017.02.016. Epub 2017 May 31.
3
Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection.TYRX可吸收抗菌包膜预防心血管植入式电子设备感染的成本效益
J Med Econ. 2018 Mar;21(3):294-300. doi: 10.1080/13696998.2017.1409227. Epub 2018 Jan 3.
4
Antibiotic envelope is associated with reduction in cardiac implantable electronic devices infections especially for high-power device-Systematic review and meta-analysis.抗生素包膜与心脏植入式电子设备感染的减少相关,尤其是对于高功率设备——系统评价和荟萃分析。
J Arrhythm. 2019 Nov 29;36(1):166-173. doi: 10.1002/joa3.12270. eCollection 2020 Feb.
5
Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis.在接受植入式心脏设备手术的心力衰竭且射血分数降低患者中引入TYRX的经济影响:基于回顾性模型的成本分析
J Med Econ. 2019 May;22(5):464-470. doi: 10.1080/13696998.2019.1581621. Epub 2019 Feb 20.
6
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.全球性随机抗生素包裹感染预防(WRAP-IT)试验:长期随访。
Heart Rhythm. 2020 Jul;17(7):1115-1122. doi: 10.1016/j.hrthm.2020.02.011. Epub 2020 Feb 19.
7
Efficacy of antibacterial envelope in prevention of cardiovascular implantable electronic device infections in high-risk patients: A systematic review and meta-analysis.抗菌封套预防高危患者心血管植入式电子设备感染的疗效:一项系统评价和荟萃分析。
Int J Cardiol. 2020 Sep 15;315:51-56. doi: 10.1016/j.ijcard.2020.03.042. Epub 2020 Mar 19.
8
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.心脏植入式电子设备程序引起的血肿的感染后果和抗生素包膜的作用:WRAP-IT 试验分析。
Heart Rhythm. 2021 Dec;18(12):2080-2086. doi: 10.1016/j.hrthm.2021.07.011. Epub 2021 Jul 17.
9
The role of an antibiotic envelope in the prevention of major cardiac implantable electronic device infections: A systematic review and meta-analysis.抗生素包膜在预防主要心脏植入式电子设备感染中的作用:一项系统评价和荟萃分析。
Medicine (Baltimore). 2020 Jun 26;99(26):e20834. doi: 10.1097/MD.0000000000020834.
10
Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis.接受抗菌心血管植入式电子设备包膜患者的风险概况和结局:一项回顾性分析。
World J Cardiol. 2022 Mar 26;14(3):177-186. doi: 10.4330/wjc.v14.i3.177.

引用本文的文献

1
Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures.心脏植入式设备手术期间医生对生物抗菌包膜的抗生素水化偏好。
Front Cardiovasc Med. 2022 Dec 22;9:1006091. doi: 10.3389/fcvm.2022.1006091. eCollection 2022.
2
Safety and Efficacy of Submuscular Implantation With Resterilized Cardiac Implantable Electronic Device in Patients With Device Infection: A Retrospective Observational Study in Taiwan.重新消毒的心脏植入式电子设备肌下植入治疗设备感染患者的安全性和有效性:台湾一项回顾性观察研究
Open Forum Infect Dis. 2022 Apr 10;9(5):ofac100. doi: 10.1093/ofid/ofac100. eCollection 2022 May.
3
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices.植入医疗器械相关细菌生物膜的环境、微生物学和免疫学特征。
Clin Microbiol Rev. 2022 Apr 20;35(2):e0022120. doi: 10.1128/cmr.00221-20. Epub 2022 Jan 19.
4
Prevention of Cardiac Implantable Electronic Device-Related Infection in Patients With Cancer: The Role of a Comprehensive Prophylactic Bundle Approach That Includes the Antimicrobial Mesh.癌症患者心脏植入式电子设备相关感染的预防:包括抗菌网片在内的综合预防性方案的作用
Open Forum Infect Dis. 2020 Sep 13;7(11):ofaa433. doi: 10.1093/ofid/ofaa433. eCollection 2020 Nov.
5
The role of an antibiotic envelope in the prevention of major cardiac implantable electronic device infections: A systematic review and meta-analysis.抗生素包膜在预防主要心脏植入式电子设备感染中的作用:一项系统评价和荟萃分析。
Medicine (Baltimore). 2020 Jun 26;99(26):e20834. doi: 10.1097/MD.0000000000020834.
6
Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement.心脏植入式电子设备植入术后的抗生素预防
J Innov Card Rhythm Manag. 2019 Aug 15;10(8):3777-3784. doi: 10.19102/icrm.2019.100804. eCollection 2019 Aug.
7
Role of antibiotic envelopes in preventing cardiac implantable electronic device infection: A meta-analysis of 14 859 procedures.抗生素包膜在预防心脏植入式电子设备感染中的作用:对14859例手术的荟萃分析
J Arrhythm. 2019 Nov 18;36(1):176-179. doi: 10.1002/joa3.12262. eCollection 2020 Feb.
8
Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.真实世界中感染预防干预措施在降低与操作相关的心脏器械感染方面的有效性:来自退伍军人事务临床评估报告和跟踪计划的见解。
Infect Control Hosp Epidemiol. 2019 Aug;40(8):855-862. doi: 10.1017/ice.2019.127. Epub 2019 Jun 4.
9
Transvenous Lead Extractions: Current Approaches and Future Trends.经静脉导线拔除:当前方法与未来趋势。
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2.
10
The Diagnosis and Treatment of Pacemaker-Associated Infection.起搏器相关感染的诊断与治疗。
Dtsch Arztebl Int. 2018 Jun 29;115(26):445-452. doi: 10.3238/arztebl.2018.0445.

本文引用的文献

1
Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.使用和不使用抗菌封套的心血管植入式电子设备感染的回顾性比较分析
J Hosp Infect. 2017 Mar;95(3):286-291. doi: 10.1016/j.jhin.2016.12.014. Epub 2016 Dec 23.
2
Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.一种生物可吸收抗菌封套预防高危受试者心脏植入式电子设备感染的疗效
J Cardiovasc Electrophysiol. 2015 Oct;26(10):1111-6. doi: 10.1111/jce.12768. Epub 2015 Sep 6.
3
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.心脏植入式电子设备感染的危险因素:一项系统评价和荟萃分析。
Europace. 2015 May;17(5):767-77. doi: 10.1093/europace/euv053.
4
Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.与使用抗菌封套作为心脏植入式电子设备植入护理标准相关的健康和经济结果
J Cardiovasc Electrophysiol. 2015 Jul;26(7):783-9. doi: 10.1111/jce.12684. Epub 2015 May 25.
5
Clinical use of antibacterial mesh envelopes in cardiovascular electronic device implantations.抗菌网袋在心血管电子设备植入中的临床应用。
Med Devices (Auckl). 2015 Jan 12;8:71-8. doi: 10.2147/MDER.S58278. eCollection 2015.
6
Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.心脏植入式电子设备感染:发生率、风险因素以及 AigisRx 抗菌封套的效果。
Heart Rhythm. 2014 Apr;11(4):595-601. doi: 10.1016/j.hrthm.2013.12.013. Epub 2013 Dec 10.
7
Predictors of mortality in patients with cardiovascular implantable electronic device infections.心血管植入式电子设备感染患者的死亡率预测因素。
Am J Cardiol. 2013 Mar 15;111(6):874-9. doi: 10.1016/j.amjcard.2012.11.052. Epub 2012 Dec 29.
8
Cardiac device infections are associated with a significant mortality risk.心脏器械感染与重大死亡风险相关。
Heart Rhythm. 2012 Apr;9(4):494-8. doi: 10.1016/j.hrthm.2011.10.034. Epub 2011 Nov 3.
9
Mortality and cost associated with cardiovascular implantable electronic device infections.与心血管植入式电子设备感染相关的死亡率和成本。
Arch Intern Med. 2011 Nov 14;171(20):1821-8. doi: 10.1001/archinternmed.2011.441. Epub 2011 Sep 12.
10
16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.1993 年至 2008 年美国起搏器和植入式心脏复律除颤器感染负担的 16 年趋势。
J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6. doi: 10.1016/j.jacc.2011.04.033.

一项关于使用抗菌封套预防心血管植入式电子设备感染的荟萃分析。

A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.

作者信息

Ali Sajid, Kanjwal Yousuf, Bruhl Steven R, Alo Mohammed, Taleb Mohammed, Ali Syed S, Kabour Ameer, Khawaja Owais

机构信息

Department of Cardiovascular Medicine, Mercy St. Vincent Hospital and Medical Center, Toledo, OH, USA.

出版信息

Ther Adv Infect Dis. 2017 May;4(3):75-82. doi: 10.1177/2049936117702317. Epub 2017 May 1.

DOI:10.1177/2049936117702317
PMID:28634537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5467856/
Abstract

OBJECTIVES

Cardiac implantable electronic device (CIED) infection has been a major clinical problem in addition to being a major financial burden. In spite of antimicrobial prophylaxis, CIED infection rates have been increasing disproportionately. We therefore conducted this meta-analysis to assess the role of TYRX antibiotic envelope for the prevention of CIED infection.

METHODS

Using extensive online search, we conducted a meta-analysis of studies reporting CIED infections with without the use of TYRX antibiotic envelope. A random-effect model was used, and between studies heterogeneity was estimated with I. All analyses were performed with RevMan (version 5.0.20).

RESULTS

Five cohort studies were included in this meta-analysis. The pooled odds ratio (OR) of included studies was 0.29 [95% confidence interval (CI): 0.09-0.94;  < 0.004]. There was evidence of heterogeneity with I of 58%. There was also evidence of publication bias on funnel plot analysis. On sensitivity analysis, no statistically significant difference was noted when stratified by study design or duration of follow-up.

CONCLUSION

The results of our study demonstrate a significant beneficial effect of TYRX antibiotic envelope for the prevention of CIED infections.

摘要

目的

心脏植入式电子设备(CIED)感染一直是一个重大临床问题,同时也是一项重大经济负担。尽管采取了抗菌预防措施,但CIED感染率仍在不成比例地上升。因此,我们进行了这项荟萃分析,以评估TYRX抗生素包膜在预防CIED感染中的作用。

方法

通过广泛的在线搜索,我们对报告使用或未使用TYRX抗生素包膜的CIED感染的研究进行了荟萃分析。采用随机效应模型,并使用I²估计研究间的异质性。所有分析均使用RevMan(版本5.0.20)进行。

结果

本荟萃分析纳入了五项队列研究。纳入研究的合并比值比(OR)为0.29[95%置信区间(CI):0.09 - 0.94;P < 0.004]。有证据表明异质性为I² = 58%。漏斗图分析也有发表偏倚的证据。在敏感性分析中,按研究设计或随访时间分层时未发现统计学显著差异。

结论

我们的研究结果表明TYRX抗生素包膜在预防CIED感染方面具有显著的有益效果。